Zobrazeno 1 - 10
of 13
pro vyhledávání: '"I. Yu. Gadaev"'
Autor:
I. Yu. Gadaev, V. I. Ershov, O. V. Bochkarnikova, I. Ya. Sokolova, D. A. Budanova, E. S. Kotova, A. S. Lishuta
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 11, Iss 6, Pp 610-617 (2015)
Clinical case of successful chemotherapy of patient with cardiac involvement in lymphoma, one of manifestations of which was the heart rhythm and conduction disorder, is presented as illustration. The data on the epidemiology of cardiac involvement i
Externí odkaz:
https://doaj.org/article/17b7bf2ad5904bde98123a78b18971de
Autor:
Yu N Belenkov, I S Ilgisonis, D. A. Budanova, O N Antyufeeva, V. I. Ershov, I. Ya. Sokolova, O. V. Bochkarnikova, I. Yu. Gadaev
Publikováno v:
Kardiologiia. 60:76-82
Aim To evaluate the dynamics of indexes of oxidative stress and markers of myocardial injury and dysfunction in patients with aggressive type lymphomas during the antitumor therapy.Material and methods This study included 75 patients with lymphoproli
Autor:
Yu N Belenkov, O. V. Bochkarnikova, D. A. Budanova, I. Yu. Gadaev, O N Antyufeeva, I. Ya. Sokolova, I S Ilgisonis, V. I. Ershov
Publikováno v:
Kardiologiia. 60:49-56
Aim To study changes in markers for myocardial direct injury and dysfunction and endothelial dysfunction (ED) indexes in patients with indolent lymphoma during the antitumor treatment.Material and methods Current antitumor therapy for lymphoma is oft
Autor:
Yu N Belenkov, D. A. Budanova, O. V. Bochkarnikova, I. Yu. Gadaev, Yu B Kochkareva, Yu Yu Kirichenko, V. I. Ershov, O N Antyufeeva, I. Ya. Sokolova
Publikováno v:
Kardiologiia. 59:47-53
Purpose: to study dynamics of indicators of oxidative stress and their role in development of cardiotoxicity in patients with lympho-proliferative diseases at the background of polychemotherapy. Materials and methods . We included into this study 30
Autor:
I. Yu. Gadaev, O. S. Pshenichnikova, V. V. Salomashkina, F. G. Perina, V. L. Surin, Nadezhda Zozulya, V. I. Ershov, D. A. Budanova
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 118-122 (2018)
The article provides review of possible mechanisms of inhibitor coagulopathies, in particular of acquired hemophilia A. This pathology is an extremely rare disease occurring in 1-2 cases in 1 million per year. In the present study we provide data for
Autor:
O. S. Pshenichnikova, D. A. Budanova, V. L. Surin, I. Yu. Gadaev, F. G. Perina, N. I. Konyashina, V. V. Salomashkina, N. I. Zozulya, O. N. Bobrova, V. I. Ershov
Publikováno v:
Russian Journal of Genetics. 54:712-716
Hemophilia A is a recessive X-linked hereditary disease, so its manifestation in women is extremely rare and can be a result of an asymmetric X-chromosome inactivation or, even more rarely, of a presence of mutations in both FVIII gene alleles. We co
Autor:
Yu N Belenkov, V. I. Ershov, I. Yu. Gadaev, D. A. Budanova, O N Antyufeeva, I S Ilgisonis, I. Ya. Sokolova
Publikováno v:
Kardiologiia. 59:64-66
Understanding mechanisms of chemotherapy cardiotoxicity is an important problem due to the lack of clear understanding of its occurrence. Development of endothelial dysfunction is considered to be one of possible ways in implementation of these side
Autor:
D. A. Budanova, O. V. Bochkarnikova, I. Ya. Sokolova, E. S. Kotova, A. S. Lishuta, I. Yu. Gadaev, V. I. Ershov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 11, Iss 6, Pp 610-617 (2015)
Clinical case of successful chemotherapy of patient with cardiac involvement in lymphoma, one of manifestations of which was the heart rhythm and conduction disorder, is presented as illustration. The data on the epidemiology of cardiac involvement i
Autor:
I Yu, Gadaev, V I, Ershov, O V, Bochkarnikova, I Ya, Sokolova, D A, Budanova, E S, Kotova, A S, Lishuta
Publikováno v:
Klinicheskaia meditsina. 94(10)
The authors report a case of rare cardiac involvement in lymphoma, one of the manifestations of which was rhythm and conduction disorders with their resolution after chemotherapy. Also presented are clinical manifestations of heart lesions in lymphom
Autor:
V I, Ershov, D A, Budanova, I Yu, Gadaev, O V, Bochkarnikova, I Yu, Sokolova, O N, Antyufeeva, S G, Nesterova
Publikováno v:
Klinicheskaia meditsina. 94(10)
Inhibitory coagulopathy is a rare variant of hemorrhagic syndrome. Acquired hemophilia A is caused by the formation of inhibitors (antibodies) to Factor VIII of the blood coagulation system leading to impaired activation of the key stage of blood clo